Although short-term findings after lung reperfusion have been extensively reported, in vivo animal studies have not described outcome beyond the immediate time period. Therefore, the authors evaluated lung injury 27 h after reperfusion. They also investigated whether attenuation of lung injury with the A3 adenosine receptor agonist MRS3558 was sustained beyond the immediate time period.
Department of Anesthesiology and Critical Care Medicine, Tel Aviv Sourasky Medical Center, 6 Weizman Street, Tel Aviv 64239, Israel. iditm@tasmc.health.gov.il
